Nxera unveils proprietary pipeline targeting obesity and metabolic disorders
New oral GLP-1 agonist aims to reshape chronic weight management New oral GLP-1 agonist aims to reshape chronic weight management
Previous Post
Porosome Therapeutics unveils breakthrough Alzheimer’s research
Next Post
Kenya achieves elimination of human African trypanosomiasis or sleeping sickness as a public health problem
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago